Search

Leah Leyendecker focuses her practice on commercial transactions driven by intellectual property, intangible assets and technology. Her experience includes reviewing, drafting and negotiating complex technology-related license and master services agreements, SaaS agreements, technology development...

Erin Westbrook assists clients in the food, beverage, agribusiness and cannabis industries with matters involving their intellectual property and business disputes. Her experience includes counseling and litigation involving trademarks, patents, copyrights, trade secrets and contracts, and she...

Darius Gambino has over 20 years of experience helping clients protect their intellectual property in the United States and abroad. Clients in industries ranging from technology and manufacturing to consumer goods and professional services rely on Darius to represent them in high stakes patent...

Dennis Ostrovsky assists clients with patent portfolios involving obtaining patents in diverse technologies such as nanomaterials, cellular analysis systems, small molecule drugs, bactericides, abrasives, drug delivery systems, dental compositions, volumetric additive manufacturing (VAM), OLED...

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...